DK0930875T3 - Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering - Google Patents

Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering

Info

Publication number
DK0930875T3
DK0930875T3 DK97942022T DK97942022T DK0930875T3 DK 0930875 T3 DK0930875 T3 DK 0930875T3 DK 97942022 T DK97942022 T DK 97942022T DK 97942022 T DK97942022 T DK 97942022T DK 0930875 T3 DK0930875 T3 DK 0930875T3
Authority
DK
Denmark
Prior art keywords
extrusion
preparation
solid pharmaceutical
pharmaceutical forms
shaping
Prior art date
Application number
DK97942022T
Other languages
English (en)
Inventor
Joerg Breitenbach
Andreas Kleinke
Stephan Kothrade
Joerg Rosenberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19637479A external-priority patent/DE19637479A1/de
Priority claimed from DE19734011A external-priority patent/DE19734011A1/de
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0930875T3 publication Critical patent/DK0930875T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
DK97942022T 1996-09-13 1997-09-11 Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering DK0930875T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19637479A DE19637479A1 (de) 1996-09-13 1996-09-13 Verfahren zur Herstellung fester pharmazeutischer Formen
DE19734011A DE19734011A1 (de) 1997-08-06 1997-08-06 Verfahren zur Herstellung fester pharmazeutischer Formen
PCT/EP1997/004984 WO1998010752A2 (de) 1996-09-13 1997-09-11 Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung

Publications (1)

Publication Number Publication Date
DK0930875T3 true DK0930875T3 (da) 2003-09-01

Family

ID=26029370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97942022T DK0930875T3 (da) 1996-09-13 1997-09-11 Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering

Country Status (19)

Country Link
US (1) US6221368B1 (da)
EP (1) EP0930875B1 (da)
JP (1) JP4975894B2 (da)
KR (1) KR20000036066A (da)
CN (1) CN1230109A (da)
AT (1) ATE239452T1 (da)
AU (1) AU720535B2 (da)
BR (1) BR9711777A (da)
CA (1) CA2265532C (da)
CZ (1) CZ82999A3 (da)
DE (1) DE59710059D1 (da)
DK (1) DK0930875T3 (da)
ES (1) ES2199373T3 (da)
HR (1) HRP970485A2 (da)
IL (1) IL128672A0 (da)
SK (1) SK26099A3 (da)
TR (1) TR199900563T2 (da)
TW (1) TW474824B (da)
WO (1) WO1998010752A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
DE19857897A1 (de) * 1998-12-15 2000-06-21 Basf Ag Verfahren zur Herstellung wäßriger Polymerdispersionen
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0106469D0 (en) * 2001-03-15 2001-05-02 Syngenta Ltd Solid formulation
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
JP2007516220A (ja) * 2003-05-06 2007-06-21 ビーピーエスアイ ホールディングス，インコーポレーテッド アクリルポリマー接着剤を含有する熱成形組成物の製造方法、医薬製剤および該製剤の製造方法
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CA2547774A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053640A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US7799744B2 (en) * 2005-03-09 2010-09-21 Halliburton Energy Services, Inc. Polymer coated particulates
ATE476997T1 (de) 2005-07-05 2010-08-15 Abbott Gmbh & Co Kg Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
JP5220745B2 (ja) * 2006-08-23 2013-06-26 バイエル・クロップサイエンス・アーゲー 農芸化学的活性物質の徐放のための新規製剤
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
EP2293779A1 (en) * 2008-04-24 2011-03-16 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
CN108421497A (zh) * 2018-04-03 2018-08-21 杨高品 药物连续化制粒的生产工艺和设备

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
DE3208791A1 (de) 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
DE3421860C2 (de) * 1984-06-13 1994-09-15 Roehm Gmbh Verfahren zum Überziehen von Arzneiformen
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JPS63222112A (ja) 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性顆粒
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4031881C2 (de) 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
GB9025372D0 (en) 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
NL9100691A (nl) * 1991-04-19 1992-11-16 Dmv Campina Bv Tabletteerhulpstof.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
DE4141268A1 (de) 1991-12-14 1993-06-17 Merck Patent Gmbh Pharmazeutische zubereitung
US5260074A (en) 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
JPH06218028A (ja) 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
EP0729748B1 (en) 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Process for producing stable medicinal composition
EP0739198B1 (en) * 1994-01-20 2003-09-17 Agresearch Limited Device for administration of beneficial materials to ruminants
AU1806895A (en) * 1994-02-23 1995-09-11 Bm Research A/S Controlled release composition

Also Published As

Publication number Publication date
AU720535B2 (en) 2000-06-01
HRP970485A2 (en) 1998-08-31
SK26099A3 (en) 2000-03-13
EP0930875B1 (de) 2003-05-07
JP2001500130A (ja) 2001-01-09
TR199900563T2 (xx) 1999-07-21
KR20000036066A (ko) 2000-06-26
ES2199373T3 (es) 2004-02-16
CZ82999A3 (cs) 1999-06-16
WO1998010752A3 (de) 1998-06-18
TW474824B (en) 2002-02-01
US6221368B1 (en) 2001-04-24
WO1998010752A2 (de) 1998-03-19
ATE239452T1 (de) 2003-05-15
IL128672A0 (en) 2000-01-31
JP4975894B2 (ja) 2012-07-11
BR9711777A (pt) 1999-08-24
DE59710059D1 (de) 2003-06-12
CA2265532C (en) 2006-04-04
AU4384697A (en) 1998-04-02
CN1230109A (zh) 1999-09-29
CA2265532A1 (en) 1998-03-19
EP0930875A2 (de) 1999-07-28

Similar Documents

Publication Publication Date Title
DK0930875T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering
DK1035841T3 (da) Fremgangsmåde til fremstilling af faste doseringsformer
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
DE59913682D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE69023896D1 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
BR9404330A (pt) Dispositivo para misturar uma composição farmacêutica com um outro agente, processo para preparar um preparado farmacêutico mediante a mistura de uma composição farmacêutica com um agente, e, processo para a aplicação oral de um preparado farmacêutico.
FR2659959B1 (fr) Procede de projection de beton et melange utilise.
ES2037020T3 (es) Procedimiento para la obtencion de formas solidas farmaceuticas.
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
DE69112837T2 (de) Wasserlösliche pentacyclische triterpen-mischung sowie deren herstellung.
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
PT1158962E (pt) Processo para a preparacao de formas de dosagem solidas que contem ciclodextrina
SE8201202L (sv) Anti-inflammatoriskt analgetiskt kataplasma
DE59909717D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
HUT60245A (en) Insecticidal compositions comprising 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)-pyrrole derivatives as active ingredient and process for producing the active ingredient
ES2083406T3 (es) Procedimiento para la obtencion de machos y moldes de fundicion.
TW350898B (en) Sliding member and manufacture thereof
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
DE69729618D1 (de) Abführmittel und verfahren zu deren herstellung
KR860003176A (ko) 연탄재를 이용한 건자재의 제조방법
SV1998000012A (es) Metodo para la preparacion de (1s, 4r) -1-azabiciclo [2.2.1] heptano-3- uno y (1r,4s), 1-azabiciclo [2.2.1] heptano-3-uno.
ES2067622T3 (es) Proceso para preparar una composicion farmaceutica.
EP0146847A3 (en) Preparation for treating burns
FI923361A0 (fi) Foerfarande foer framstaellning av kompositmaterial.